Yona Levites
- Department of Pharmacology & Chemical Biology
Associate Professor
Overview
Dr. Levites is an Associate Professor at the CND and the Department of Pharmacology and Chemical Biology. She received her PhD in the laboratory of Professor Moussa Youdim at the Technion Israel Institute of Technology, working on the benefits of Green Tea polyphenols in models of Parkinsons Disease. She continued her training as a postdoctoral fellow in the lab of Professor Todd Golde where she developed recombinant antibody fragments against amyloid beta and their delivery to the CNS via Adeno Associated virus. She continued this path at the CTRND at the University of Florida and her primary research there was focused on designing, engineering, and testing recombinant therapies for neurodegenerative disorders. These diseases are characterized by accumulation of misfolded proteins in the brain, initiating a cascade of neurotoxic and inflammatory events leading eventually to brain organ failure. In the recent years immunotherapeutic approach, specifically targeting misfolded proteins accumulation in the CNS has been very promising, although is facing many challenges in clinic. Dr. Levites group cloned variable regions from many newly developed antibodies against these proteins, modified them to increase their stability and efficacy and further test these novel therapeutics in vitro, cell culture, as well as in various mouse models.
The goal of her research is to get preclinical immunotherapy research to the stage where these agents can be evaluated in clinic. Additionally, Dr. Levites is investigating, as a part of a collaborative RF1 project with Drs. Golde, Seyfried and Dr. Prokop (UF), a role of Amyloid Associated Proteins in the pathology of Alzheimers disease. She also plays a key role in developing AAV toolkit, looking for optimal ways to deliver AAV to the CNS and achieve highest levels of gene expression in areas of interest.
Research
Publications
-
Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates A accumulation.
Acta Neuropathol Commun Volume: 13 Page(s): 51
03/07/2025 Authors: Koller EJ; McFarland KN; Angelle C; Howard J; Ryu D; Dillon KD; Erquizi A; Beheray M; De La Cruz EG; Cruz PE -
Integrative proteomics identifies a conserved A amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease.
Cell Rep Med Volume: 5 Page(s): 101669
08/20/2024 Authors: Levites Y; Dammer EB; Ran Y; Tsering W; Duong D; Abreha M; Gadhavi J; Lolo K; Trejo-Lopez J; Phillips J -
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid.
Alzheimers Dement Volume: 20 Page(s): 4043 - 4065
06/01/2024 Authors: Wojtas AM; Dammer EB; Guo Q; Ping L; Shantaraman A; Duong DM; Yin L; Fox EJ; Seifar F; Lee EB -
A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-A scFvs: Applications for gene therapies.
Mol Ther Methods Clin Dev Volume: 31 Page(s): 101146
12/14/2023 Authors: Moore BD; Ran Y; Goodwin MS; Komatineni K; McFarland KN; Dillon K; Charles C; Ryu D; Liu X; Prokop S -
A Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease.
bioRxiv
12/07/2023 Authors: Levites Y; Dammer EB; Ran Y; Tsering W; Duong D; Abreha M; Gadhavi J; Lolo K; Trejo-Lopez J; Phillips JL -
AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model.
EMBO Mol Med Volume: 14 Page(s): e09824
04/07/2022 Authors: Marino M; Zhou L; Rincon MY; Callaerts-Vegh Z; Verhaert J; Wahis J; Creemers E; Yshii L; Wierda K; Saito T -
Intracerebral but Not Peripheral Infection of Live Porphyromonas gingivalis Exacerbates Alzheimer's Disease Like Amyloid Pathology in APP-TgCRND8 Mice.
Int J Mol Sci Volume: 23
03/19/2022 Authors: Aravindraja C; Sakthivel R; Liu X; Goodwin M; Veena P; Godovikova V; Fenno JC; Levites Y; Golde TE; Kesavalu L -
Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse A plaque pathology when injected into newborn mouse hosts.
Free Neuropathol Volume: 3 Page(s): 9
01/11/2022 Authors: Moore BD; Levites Y; Xu G; Hampton H; Adamo MF; Croft CL; Futch HS; Moran C; Fromholt S; Janus C -
Complexes of Soluble a-Synuclein and Amyloid-beta with Their Cognate Antibodies Activate the NLRP3 Inflammasome in hiPSC-Derived Microglia
Volume: 90 Page(s): S169 - S169
10/01/2021 Authors: Trudler D; Nazor KL; Eisele YS; Grabauskas T; Dolatabadi N; Parker J; Sultan A; Zhong Z; Goodwin MS; Levites Y -
Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.
Alzheimers Dement Volume: 17 Page(s): 984 - 1004
06/30/2021 Authors: Li H-D; Funk CC; McFarland K; Dammer EB; Allen M; Carrasquillo MM; Levites Y; Chakrabarty P; Burgess JD; Wang X